Iris To
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- CAR-T cell therapy research
Papers in
-
- Lymphoma Diagnosis and Treatment 14
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Lihua E. Budde (14 shared papers)Sarit Assouline (10 shared papers)Pratyush Giri (6 shared papers)Matthew Ku (5 shared papers)Nancy L. Bartlett (7 shared papers)Michael C. Wei (11 shared papers)Matthew J. Matasar (7 shared papers)Elicia Penuel (5 shared papers)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (2 papers)Clinical Lymphoma Myeloma & Leukemia (6 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Iris To
10 papers receiving 126 citations
Peers
Comparison fields: 5 of 17
- Pathology and Forensic Medicine 102
- Oncology 119
- Genetics 22
- Radiology, Nuclear Medicine and Imaging 44
- Dermatology 11
Countries citing papers authored by Iris To
This map shows the geographic impact of Iris To's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris To with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris To more than expected).
Fields of papers citing papers by Iris To
This network shows the impact of papers produced by Iris To. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris To. The network helps show where Iris To may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris To, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 27 | |
| 2 | 2022 | 21 | |
| 3 | 2023 | 18 | |
| 4 | 2021 | 14 | |
| 5 | 2023 | 14 | |
| 6 | 2022 | 12 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2024 | 1 | |
| 10 | 2021 | 1 | |
| 11 | 2024 | 0 | |
| 12 | 2024 | 0 | |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 | |
| 15 | 2024 | 0 |
About Iris To
Iris To is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Radiology, Nuclear Medicine and Imaging and Dermatology, having authored 15 papers that have together received 127 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cutaneous lymphoproliferative disorders research (4 papers), Biosimilars and Bioanalytical Methods (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (102 citations), Oncology (119 citations), Genetics (22 citations), Radiology, Nuclear Medicine and Imaging (44 citations) and Dermatology (11 citations). Iris To has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Lihua E. Budde, Sarit Assouline, Pratyush Giri, Matthew Ku, Nancy L. Bartlett, Michael C. Wei, Matthew J. Matasar, Elicia Penuel, Shen Yin and Chan Y. Cheah. Their work appears in journals such as Blood, Journal of Clinical Oncology and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.